Diabetes

Diabetics stock up on insulin over Brexit fears

Diabetics and insulin providers in Britain are stockpiling the precious medicine to avoid potential shortages in case Britain leaves the European Union without a deal in just over month's time.

Genetics

Roche to buy US gene therapy group Spark for $4.3 bn

Swiss pharmaceuticals giant Roche said Monday it reached a deal worth $4.3 billion (3.7 billion euros) to buy US group Spark Therapeutics, which specialises in the development of gene therapy drugs.

page 1 from 23